When accounting for confounding factors, each 1 g/dL drop in albumin levels among patients with favorable survival was associated with a 1.78-fold elevated risk, while among patients with poor survival, the risk increased by 1.99-fold; ii) A consistent and negative nonlinear association between albumin levels and cancer mortality was observed, irrespective of cancer malignancy. Here, ALB is linked to cancer.